Neuronetics, Inc.

Date Founded
2001

Innovation
Using Transcranial Magnetic Stimulation (TMS), Neuronetics develops safe therapies for disorders of the central nervous system, including major depression, schizophrenia, OCD, mania and epilepsy.

Funding
The company has completed A, B, and C rounds of funding, raising a total of $69.4 million.

Contact
One Great Valley Parkway, Suite 2
Malvern, PA 19355
610.640.4202 phone
610.640.4206 fax

www.neuronetics.com